| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 18.024 | 40.607 | 48.463 | 84.617 |
| Total Income - EUR | - | - | - | - | - | - | 18.025 | 41.441 | 50.053 | 84.785 |
| Total Expenses - EUR | - | - | - | - | - | - | 22.348 | 41.684 | 47.332 | 83.262 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -4.322 | -243 | 2.721 | 1.523 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -4.503 | -657 | 2.221 | -74 |
| Employees | - | - | - | - | - | - | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Reflexpharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 756 | 583 | 406 | 229 |
| Current Assets | - | - | - | - | - | - | 9.317 | 13.305 | 18.756 | 27.154 |
| Inventories | - | - | - | - | - | - | 4.615 | 7.121 | 9.675 | 10.052 |
| Receivables | - | - | - | - | - | - | 4.480 | 5.829 | 7.452 | 11.313 |
| Cash | - | - | - | - | - | - | 222 | 355 | 1.629 | 5.789 |
| Shareholders Funds | - | - | - | - | - | - | -4.462 | -5.133 | -2.897 | -2.955 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 14.535 | 19.021 | 22.059 | 30.338 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Reflexpharm S.r.l.